Gulnaz Kh. Lasyanova

Gulnaz Kh. Lasyanova

Auto-generated profile, based on publicly available information

Gulnaz Kh. Lasyanova

Bashkir State Medical University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2023 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
GLG. Kh. Lasynova
G. Kh. Lasynova
ILIrina Lakman
Irina Lakman
DGDiana Gareeva
Diana Gareeva
AAAlexander Agapitov
Alexander Agapitov
LSLiana Sadikova
Liana Sadikova
NZNaufal Zagidullin
Naufal Zagidullin
Due to the large number of complications and decreased quality of life after coronavirus disease (COVID-19), physical and psychological rehabilitation of patients is relevant. However, the effectiveness of rehabilitation on endpoints has not yet been demonstrated.Aim. To determine the effectiveness of different rehabilitation options in hospitalized patients with COVID-19 on the development of long-term adverse cardiovascular events 1 year after discharge.Material and methods. In a single-center, non-randomized observational study, 3 groups of patients were formed after hospitalization with COVID-19: I — with telemedicine rehabilitation (n=118), II — with rehabilitation in a specialized department (n=46) and III — without rehabilitation (n=175). After 1-year followup, groups were compared regarding following endpoints: cardiovascular mortality, myocardial infarction, stroke, pulmonary embolism, atrial fibrillation and cardiovascular hospitalization. Propensity score matching analysis was used to optimize differences between comparison groups.Results. Rehabilitation after hospitalization of patients with COVID-19, both in the hospital and remotely for 1 year, helps to reduce cardiovascular hospitalization rate. In addition, remote rehabilitation reduces cardiovascular mortality.Conclusion. Both rehabilitation options reduce the incidence of cardiovascular hospitalization compared to no rehabilitation.

25 November 2022 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
ILIrina Lakman
Irina Lakman
GLG. Kh. Lasynova
G. Kh. Lasynova
RGR. R. Gimatova
R. R. Gimatova
DGDiana Gareeva
Diana Gareeva
PDP. A. Davtyan
P. A. Davtyan
NZNaufal Zagidullin
Naufal Zagidullin
Due to the rather specific course of COVID-19, the question of what day after the start of hospitalization should be expected to be the maximum risk of death in patients both during hospitalization and after discharge is relevant.Aim. The aim of the study was to determine the time of maximum risk of death during hospitalization of patients with COVID-19 as well as after their discharge from the hospital.Methodology and Research Methods. A total of 2,410 patients hospitalized with a diagnosis of COVID-19 were retrospectively studied. Inhospital 28-day mortality rate was 131 patients, and 28-day mortality rate after discharge from the hospital was 9. The accelerated failure time model (AFT) was used to determine the time of maximum risk of death in patients with COVID-19 after hospitalization as well as after discharge from the hospital during the period up to 28 days.Results. Without taking into account the influence of pathological values of other risk factors, lethal outcomes in patients occurred on days 9-11 after admission to hospital. Age over 60 years and the elevated levels of D-dimer, glucose, urea, creatinine, AST, and C-reactive protein were the risk factors (p < 0.01) that shortened the time to death, except for total protein, which lengthened this period. The maximum risk of death in patients after discharge from the hospital occurred on days 13-25, and an increase in creatinine and a decrease in INR were associated with a shorter time to death.Conclusion. The periods of maximum risk of death as well as the factors affecting these periods in patients with COVID-19 were determined for both hospital stay (days 9-11) and time after discharge from hospital (days 13-25).

31 March 2026 in PERSONALITY IN A CHANGING WORLD: HEALTH, ADAPTATION, DEVELOPMENT
Verified
Journal Article
Closed access
CPChulpan A. Petrova
Chulpan A. Petrova
EGEvgeny O. Goldyrev
Evgeny O. Goldyrev
GLGulnaz K. Lasynova
Gulnaz K. Lasynova
Background. Anxiety and depression often complicate the postoperative period in cardiac surgery patients, worsening their quality of life. Standard therapy is not always sufficiently effective or has limitations, which determines the relevance of searching for non-drug correction methods, including those using virtual reality (VR) technologies. Aim. To study the effectiveness of the combined use of VR and binaural beats (BB) for reducing anxiety and depression levels in patients in the early postoperative period of coronary artery bypass grafting (CABG). Methods. A controlled study included 200 patients after CABG with signs of anxiety and depression. Using simple randomization, an experimental group (n=100, a 14-day course of VR relaxation combined with BB at frequency of 11-12 Hz) and a control group (n=100, standard therapy only) were formed. Psychodiagnostics was performed using the Beck Anxiety and Depression Inventories, the HADS, the SOM PAI Somatic Symptom Scale, the Cognitive Avoidance Questionnaire (CAQ), and the Spielberger-Khanin State-Trait Anxiety Inventory before and after the intervention. Results. The experimental group showed a statistically significant decrease in scores on the Hospital Anxiety Scale (from 16 to 11), the Beck Anxiety Inventory (from 36 to 32) and Beck Depression Inventory (from 28 to 24), as well as state anxiety (from 46 to 38) (p <0.001). In the control group, the positive dynamics were less pronounced. Conclusion. The combined use of virtual reality technologies and binaural beats is an effective additional method for correcting anxiety and depressive states in patients after CABG, contributing to the improvement of psychoemotional status during the rehabilitation process.

25 November 2022 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
ILIrina Lakman
Irina Lakman
GLG. Kh. Lasynova
G. Kh. Lasynova
RGR. R. Gimatova
R. R. Gimatova
DGDiana Gareeva
Diana Gareeva
PDP. A. Davtyan
P. A. Davtyan
NZNaufal Zagidullin
Naufal Zagidullin
Due to the rather specific course of COVID-19, the question of what day after the start of hospitalization should be expected to be the maximum risk of death in patients both during hospitalization and after discharge is relevant.Aim. The aim of the study was to determine the time of maximum risk of death during hospitalization of patients with COVID-19 as well as after their discharge from the hospital.Methodology and Research Methods. A total of 2,410 patients hospitalized with a diagnosis of COVID-19 were retrospectively studied. Inhospital 28-day mortality rate was 131 patients, and 28-day mortality rate after discharge from the hospital was 9. The accelerated failure time model (AFT) was used to determine the time of maximum risk of death in patients with COVID-19 after hospitalization as well as after discharge from the hospital during the period up to 28 days.Results. Without taking into account the influence of pathological values of other risk factors, lethal outcomes in patients occurred on days 9-11 after admission to hospital. Age over 60 years and the elevated levels of D-dimer, glucose, urea, creatinine, AST, and C-reactive protein were the risk factors (p < 0.01) that shortened the time to death, except for total protein, which lengthened this period. The maximum risk of death in patients after discharge from the hospital occurred on days 13-25, and an increase in creatinine and a decrease in INR were associated with a shorter time to death.Conclusion. The periods of maximum risk of death as well as the factors affecting these periods in patients with COVID-19 were determined for both hospital stay (days 9-11) and time after discharge from hospital (days 13-25).

27 May 2025 in Cardiosomatics
Verified
Journal Article
Open access
PDF file
AGAdelina G. Garifullina
Adelina G. Garifullina
BBBulat A. Bakirov
Bulat A. Bakirov
GLGulnaz Kh. Lasyanova
Gulnaz Kh. Lasyanova
EGEvgeny O. Goldyrev
Evgeny O. Goldyrev
DKDmitry Kudlay
Dmitry Kudlay
КАКудлай Дмитрий Анатольевич
Кудлай Дмитрий Анатольевич
Chronic myeloproliferative disorders (CMPDs) are a group of clonal hematopoietic disorders primarily affecting elderly patients. These diseases are associated with an increased risk of multiple complications. One of the key comorbidities in these patients is sarcopenia—a progressive loss of muscle mass, strength, and functionality, which significantly worsens quality of life and disease prognosis. The aim of this study is to systematize current data on the impact of sarcopenia on the prognosis of patients with CMPDs and to summarize recommendations for its early diagnosis and management to improve clinical outcomes. This review presents data on the epidemiology, pathogenesis, and clinical significance of sarcopenia in CMPD patients. Special attention is given to the role of chronic inflammation, protein metabolism disorders, side effects of anticancer therapy, and age-related changes in the development of muscle atrophy. The importance of early diagnosis is emphasized, including the use of modern tools such as the SARC-F questionnaire, bioimpedance analysis, and physical performance tests. Management strategies for sarcopenia are discussed, including physical exercise, nutritional support, and other approaches that may improve prognosis and quality of life. This work is highly relevant for hematologists, geriatricians, and rehabilitation specialists involved in the care of CMPD patients. Research on sarcopenia in CMPDs is an urgent priority, as timely diagnosis and intervention can significantly influence clinical outcomes.

12 November 2025 in N.N. Priorov Journal of Traumatology and Orthopedics
Verified
Journal Article
Open access
PDF file
BMBulat Sh. Minasov
Bulat Sh. Minasov
RYRasul R. Yakupov
Rasul R. Yakupov
VAVladislav N. Akbashev
Vladislav N. Akbashev
ABAzat R. Bilyalov
Azat R. Bilyalov
TMTimur B. Minasov
Timur B. Minasov
АААхмельдинова Айгуль Абузаровна
Ахмельдинова Айгуль Абузаровна
BACKGROUND: The increasing number of knee arthroplasty procedures and associated complications underscores the need for the implementation of technologies that enhance the precision of implant component positioning and improve functional outcomes. AIM: This study aimed to assess the precision of robotic knee arthroplasty in comparison with the manual technique based on clinical, radiological, and stabilometric data. METHODS: This cohort-controlled interventional single-center prospective randomized open-label study included 60 patients (aged 18–75 years) with stage III knee osteoarthritis. The patients were randomly assigned to the robotic arthroplasty group (30 individuals) or the manual arthroplasty group (30 individuals). Evaluation was performed 6 months postoperatively using clinical (VAS, ROM), radiological (LDFA, MPTA, rotational parameters), and stabilometric indicators. High-precision scales and 3D modeling were used to analyze the mass of the cement mantle. RESULTS: The robotic technique demonstrated superiority in the precision of component positioning: deviations of less than 1° in LDFA and MPTA were recorded in 93% and 66% of patients, respectively (compared with 23% and 9.4% in the manual technique group). The mean range of motion was 109° versus 106.2°, and the VAS pain score was 3.7 versus 4.2. The robotic technique ensured lower variability in cement mass and cement mantle thickness. CONCLUSION: Robotic arthroplasty surpasses the manual technique in terms of component positioning precision, cement mass distribution, and functional outcomes. Despite the absence of statistically significant differences (p 0.05), the observed trends in favor of the robotic approach render it preferable for widespread clinical application.